CausalSentinel

Protein Dossier — HGF (Hepatocyte growth factor)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Non-cancer illness code self-reported: hypopituitarism 1.03 0.312 9.90e-04 Wald ratio 1 cis NA
Non-cancer illness code self-reported: retinal detachment 0.481 0.16 0.00262 Wald ratio 1 cis NA
Age at menarche 0.0978 0.0355 0.0058 Wald ratio 1 cis NA
Non-cancer illness code self-reported: osteoporosis 0.24 0.0916 0.00879 Wald ratio 1 cis NA
Diagnoses - main ICD10: G56 Mononeuropathies of upper limb 0.222 0.0883 0.0118 Wald ratio 1 cis NA
Fasting insulin -0.0412 0.0185 0.0263 Wald ratio 1 cis NA
Cancer code self-reported: basal cell carcinoma 0.261 0.118 0.0264 Wald ratio 1 cis NA
HOMA-IR -0.0515 0.0237 0.0297 Wald ratio 1 cis NA
ER-negative Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis) 0.144 0.0685 0.0353 Wald ratio 1 cis NA
Small vessel disease 0.453 0.219 0.0389 Wald ratio 1 cis NA
Forearm bone mineral density 0.181 0.0925 0.0501 Wald ratio 1 cis NA
Non-cancer illness code self-reported: joint disorder 0.307 0.159 0.0534 Wald ratio 1 cis NA
…and 84 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-2681_23_2 HGF Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

118 association rows across 67 traits (99 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating HGF levels (id: OID00522_OID20656) 3e-81 rs5745687 4 GCST90859878 no MR -> candidate analysis
Circulating HGF levels (id: OID00706_OID20656) 5e-59 rs5745687 4 GCST90860049 no MR -> candidate analysis
Circulating HGF levels (id: OID00803_OID20656) 3e-56 rs5745687 4 GCST90860133 no MR -> candidate analysis
HGF protein levels 4e-52 rs5745687 2 GCST90469449 no MR -> candidate analysis
Facial appearance 3e-35 rs28584384 1 GCST90128425 no MR -> candidate analysis
Hepatocyte growth factor levels 9e-35 rs554133413 12 GCST90247875 no MR -> candidate analysis
Sex hormone-binding globulin levels adjusted for BMI 1e-32 rs1229492 4 GCST90012110 no MR -> candidate analysis
Cerebrospinal fluid protein HGF levels 3e-31 rs10252734 1 GCST90943462 no MR -> candidate analysis
Sex hormone-binding globulin levels 9e-27 rs1229492 10 GCST90012111 no MR -> candidate analysis
Unsupervised deep imaging phenotypes (UDIP-FA) 2e-20 rs10252734 1 GCST90860937 no MR -> candidate analysis
Glycoprotein acetyls levels 3e-20 rs1229480 2 GCST90501111 no MR -> candidate analysis
Endothelial growth factor levels 4e-19 rs5745687 1 GCST002731 no MR -> candidate analysis
…and 55 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 2009 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
hearing loss, autosomal recessive 0.744 established (curated) no MR -> candidate analysis
prostate carcinoma 0.53 common-variant locus no MR -> candidate analysis
kidney disorder 0.59 common-variant locus no MR -> candidate analysis
Sensorineural hearing impairment 0.559 established (curated) no MR -> candidate analysis
ovarian neoplasm 0.499 common-variant locus no MR -> candidate analysis

Of the 5 rows above, 5 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 20 known modulators (Hepatocyte growth factor receptor)
gnomAD constraint pLI=1, LOEUF=0.456 — LoF-INTOLERANT
GWAS Catalog 52 unique SNPs / 104 rows
ClinVar 356 records; 3 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance